Stoke Therapeutics Chief Medical Officer Ticho Barry sold 5,545 shares in two transactions on 2026-09-01, at prices from $30.51 to $31.06 per share. The transactions leave Barry owning 20,110 shares, giving investors a precise post-sale ownership figure alongside the insider transaction.

Key Highlights

  • Ticho Barry sold 5,545 Stoke Therapeutics shares.
  • The sales occurred across two separate transactions on 1 September 2026.
  • The reported prices ranged from $30.51 to $31.06 per share.

Stoke Therapeutics, Inc. (NASDAQ: STOK) Chief Medical Officer Ticho Barry sold 5,545 shares, leaving him with 20,110 shares after the transactions.

5,545 Shares Sold Across Two Transactions

Barry’s reported activity covered a total of 5,545 Stoke Therapeutics shares. The transactions were carried out under transaction code S and occurred on the same date. The lower end of the price range was $30.51 per share, while the highest reported price was $31.06 per share. Barry was identified in the transaction as Stoke Therapeutics’ chief medical officer. The stated post-transaction balance was 20,110 shares. That figure represents Barry’s ownership after the two sales.